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ABSTRACT
The positive-stranded coronavirus genome, at 32 kilobases in length, is the largest
known viral RNA genome, and internal cis-signaling elements directing its replication
have been described only within the last ten years. The bovine coronavirus genome
encodes 26 proteins in the region between the 5'-terminal 210-nt untranslated region and
the 3'-terminal 298-nt untranslated region. Here, genes for 5 of the 26 proteins were
cloned into bacterial expression plasmids for the long-term goals of characterizing
enzymatic and RNA binding properties. These genes encode enzymes postulated to
interact directly with the cis-acting RNA elements and carry out RNA synthesis, namely,
the RNA-dependent RNA polymerase, the helicase, the exonuclease, the endonuclease,
and the 2'-O-methyltransferase. For a detailed analysis, bacterially-expressed BCoV 2'
O-Methyltransferase was purified and (i) tested for enzymatic activity, which is
presumably a 2'-O-methylation of 5'-terminal cap structures, and (ii) tested for its
binding to terminal genomic regions known to contain cis-acting replication elements.
Methyltransferase activity was not found, suggesting the proper conditions were not met
or the proper template was not used, or perhaps, as with many viral enzymes made from a
polyprotein precursor, it does not function as a unit-length molecule. Using the
electrophoretic mobility shift assay, the 2 '-O-Methyltransferase was found to bind cis
acting stem-loop IV in the 5' untranslated region, but does not bind other cis-acting
elements, including the region in gene 1 containing stem-loops V and VI or the 3'proximal cis-acting bulged stem-loop and pseudoknot. The results of this study suggest
that the putative bovine coronavirus 2'-O-Methyltransferase uses stem-loop IV as a
binding site to carry out methyltransferase function(s) yet to be discovered.
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CHAPTER I
LITERATURE REVIEW ON REPLICATION PROTEINS OF THE BOVINE
CORONAVIRUS
The Coronavirus Family

The family Coronaviridae (9) is one of 17 families of animal RNA viruses, each
distinguished by one or more unique feature in structure or replication strategy. The
Coronaviridae belong to the order Nidovirales, to which two other families, the
Arteriviridae and the Roniviridae, also belong (10). Coronaviruses are enveloped, single

stranded, positive-sense RNA viruses possessing a genome of 28-32 kilobases in length,
the largest RNA genome known for any RNA virus. Coronaviruses are divided into three
groups named Groups 1, 2 and 3, based on antigenic differences. Genome sequence
differences support this classification. There is continuing debate with regard to which
group the Severe Acute Respiratory Syndrome coronavirus (SARS-CoV) belongs. Recent
evidence suggests it most closely fits with Group 2 coronaviruses of which the bovine
coronavirus (BCoV) is a member (Figure 1-1) (32). Long before the discovery of the
SARS-CoV in the spring of 2003, much research had been done on the replication
strategy of coronaviruses and on the pathogenesis of many important human and animal
coronaviruses.

These included the avian infectious bronchitis virus, the porcine

transmissible gastroenteritis virus, the bovine coronavirus, the feline infectious peritonitis
virus, the mouse hepatitis viruses and the human respiratory coronaviruses. The mouse
hepatitis coronavirus has been especially intensely studied as a model for coronaviruses
in animals and it was with this virus that many of the intriguing features of coronaviruses
were first described. These include extremely high rates of recombination among viral
1
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Porcine epidemic
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Mouse hepatitis
coronavirus (MHV)
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Human respiratory
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(HCoV-OC43)
Porcine
hemagglutinating
encephalomyelitis
coronavirus (HEV)
Rat coronavirus (RtCoV)
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enteric
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Figure I-1. Taxonomy of coronaviruses. Coronaviruses are divided into three
groups as depicted here. Representative members of each group are also shown. The
placement of the SARS coronavirus is still under debate, with some investigators
proposing it belongs to an entirely new group, Group 4 (32).
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strains (approaching 10%) and long-term viral persistence in the host (in some cases the
life of the mouse, over 700 days) that often accompanies a demyelinating encephalitis
(18) (hence making this an experimental model for multiple sclerosis) (34). With the
feline infectious peritonitis virus, immune-mediated disease was found (13). Since the
discovery of the SARS-CoV, research on coronaviruses has intensified in part because of
its severity as a human pathogen and the consequential need for new vaccines and
therapeutic agents. Intensified research has also led to the discovery of SARS-CoV-like
viruses in horseshoe bats in Southeast Asia. The identification of key steps in the
coronavirus life cycle is now more important than ever as they represent potential target
sites for drug design. Among the challenges is a detailed characterization of the enzymes
involved in coronavirus genome replication.

Coronavirus Replication Strategy

The genome of the coronavirus, as with most positive-strand RNA viruses, upon
entry into a cell acts as mRNA for synthesis of the proteins responsible for virus
replication. In the coronavirus, the proteins with enzymatic function responsible for
genome replication appear to all come from open reading frame (ORF) 1, also called the
replicase gene (Fig. I-2). (Although this is technically a polycistronic gene and the
individual products of the gene are derived by proteolytic processing of the ORF 1 gene
product, for ease of reference in this thesis, ORF 1 will be considered to be comprised of
16 separate genes, each encoding a separate protein.) ORF 1ab is translated through a -1
ribosomal frameshifting event which occurs at the slippery sequence, UUUAAAC,
present at the junction of ORFs 1a and 1b. From ORF 1a comes two proteases, the minor
3
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Figure I-2. Schematic representation of the BCoV genome. A. The full-length
BCoV genome. This depicts ORF 1 (the fused ORF la and ORF lb) also called the
replicase gene in the 5' proximal two-thirds of the genome, and the structural protein
genes in the 3' proximal one-third of the genome. B. A close-up representation of the
replicase gene showing the positions of regions encoding the nonstructural proteins.
These are made as a polyprotein that are proteolytically processed by viral proteases
encoded within ORF la. (For ease of description in this thesis, the short regions
encoding nsp 1-16 are called genes.) The numbers inside the boxes representing nsp 1,
nsp 2, and nsp 8 refer to the molecular weight of the protein products. A very small
protein of 14 amino acids exists at the 3' end of ORF la and is called nsp 11(7, 32).
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protease, a papain-like protease (PLP-1 and PLP-2), and the mam protease, a
picomavirus 3C-like serine protease (3CL), that together cleave the ORF la and lab
polyproteins into the 16 nonstructural protein products (named nsp 1 through nsp 16).
From ORF lb come five proteins (nsp 12 through nsp 16), all enzymes, predicted to play
a direct role in RNA replication and transcription (i.e., the synthesis of sg mRNAs).
These are identified by viral genomics analyses to be the RNA-dependent RNA
polymerase (RdRP) (nsp 12), the helicase (Hel) (nsp 13), the 3' to 5' exonuclease (ExoN)
(nsp 14), the poly(U)-specific endoribonuclease (EndoN) (nsp 15), and the S
adenosylmethionine-dependent ribose 2'-O-Methyltransferase (2'-O-MT) (nsp 16)
(Figure 1-2) (32). These proteins are presumably used to replicate the viral genome
(replication) and to make a 3'-coterminal nested set of subgenomic mRNAs
(transcription), processes which occur in the cytoplasm in as yet uncharacterized
membrane-associated replication and transcription complexes. In coronaviruses (as in
arteriviruses, the only other family known to do it), the transcription process is uniquely
discontinuous since a 5'-leader sequence (ranging from 65 to 93 nts in length in
coronaviruses), encoded only at the 5'-terminus of the genome, gets placed onto the 5'
end of each subgenomic mRNA. From these subgenomic mRNAs, only the 5'-most open
reading frame (ORF) is translated to give rise to viral structural proteins.

The

coronavirus structural proteins include the spike glycoprotein (S), the envelope protein
(E), the membrane glycoprotein (M), and the nucleocapsid phosphoprotein (N). Various
other proteins (2-5) of unknown function, often referred to as luxury or nonstructural
proteins, are also made (4, 39).

5

The Bovine Coronavirus (BCoV) Model System

The molecular biology of bovine coronavirus replication was initially studied in
our laboratory because BCoV was one of the few culturable group 2 coronaviruses at the
time (1976) that caused natural disease in the gastrointestinal tract. The aim at that time,
as now, was to learn the details of virus replication in the hope of developing anti
coronaviral chemotherapeutic agents. The molecular biology of BCoV was therefore
studied in parallel with a few other key coronaviruses, primarily the mouse hepatitis
coronavirus (MHV) and porcine transmissible gastroenteritis virus, and fundamental
discoveries about coronavirus replication were made in all three viruses (9). The unique
contributions made with BCoV were (i) a molecular description and characterization of
the Hemagglutinin-Esterase structural glycoprotein, a protein phylogenetically related to
the HE protein in group C influenza viruses, that appears to contribute to the
neurotropism of some group 2 coronaviruses and that is not made in most strains of MHV
or in any virus in groups 1 and 3 (21, 24). (ii) confirmation of the presence of
subgenomic mRNA minus strands (that contributed in a major way to the current model
of coronavirus transcription) (20). (iii) the discovery and characterization of a simple
defective interfering RNA (the simplest of all coronavirus DI RNAs) that is comprised of
the two ends of the viral genome (the 5' 498 nts and the 3' 1635 nts) and that replicates in
the presence of the parent helper virus (5). This 2.2 kilobase DI RNA has been a major
tool in the discovery and characterization of the cis-acting elements of coronavirus
genome replication (6, 30, 31, 36, 37).

6

Cis-Acting RNA Elements for Genome Replication in BCoV

Seven cis-acting RNA replication elements have been described to date for the 2.2
kilobase BCoV DI RNA, a minigenome, that presumably are also required for the
replication of the full-length viral genome (Figure 1-3). (i) The 5'-terminal 84 nts in the
BCoV genome which contains two stem-loops, named stem-loops I and II, is a sequence
required for minigenome replication (6). However, since these stem-loops are not highly
conserved in coronaviruses, even among the group 2 coronaviruses, it is not likely that
the higher-order structures, per se, are required for the cis-acting function. (ii) The 5'proximal stem-loop III is a highly-conserved higher-order structure in all coronaviruses,
based on mfold predictions by the Zuker algorithm (40), that is required as a higher-order
structure in both the positive and negative strands for minigenome replication (30). (iii)
The 5'-proximal stem-loop IV is a highly-conserved higher-order structure in group 2
coronaviruses that has a homolog in all coronaviruses and is a required higher-order
structure in the positive strand for minigenome replication (31 ). (iv) The 5'-proximal
stem-loop VI is a higher-order structure mapping within the nsp 1 coding region that is
conserved in group 2 coronaviruses and is required as a higher-order structure m
minigenome replication (Brown, Nixon, Senanayake and Brian, manuscript m
preparation). (v) The 3'-proximal bulged stem-loop and adjacent pseudoknot that map
just downstream of the N stop codon within the 3' untranslated region function together
as a cis-acting element in minigenome replication (36). This element is highly-conserved
in group 2 coronaviruses and has been shown to function as a cis-acting element in the
MHV minigenome and genome as well (17). (vi) The 3 '-proximal octameric sequence
GGAAGAGC found in all coronaviruses sequenced to date is part of a predicted stem7
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Figure 1-3. Schematic representation of the seven cis-acting replication elements
in the 5' and 3' termini of the BCoV genome and in the nsp 1 coding region. A. BCoV 5'
UTR and part of the nsp 1 coding region depicting (i) stem-loops I and II (which together
function as a cis-acting element), (ii) stem-loop III, (iii) stem-loop IV, and (iv) stem-loop
VI. B. BCoV 3' UTR depicting (v) 5'-proximal bulged stem loop and adjacent
pseudoknot (which together function as a cis-acting element), (vi) 3 '-proximal bulged
stem-loop with the internal GGAAGAGC octameric sequence, and (vi) poly (A) tail.
Numbers represent nucleotide positions from the respective termini.
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loop in coronaviruses in groups 1, 2 and 3 and is required as a cis-acting sequence in the
replication of the BCoV minigenome (Wu and Brian, unpublished). (vii) The 3'terminal poly(A) tail is a cis-acting element in minigenome replication (33).
It is presumed that the cis-acting RNA elements function through interactions
with viral and, or, cellular proteins. To date, however, only a few of these interactions
have been identified, and, where identified, it is not yet been established whether the
RNA-protein interactions are required for the cis-acting function. In relation to the seven
identified cis-acting elements in the BCoV (and closely-related MHV) system, the
following can be said. (i) It has been shown in MHV that the N protein binds the
UCUAAAC leader associated transcription-regulating core sequence within the first 84nt cis-acting element with high affinity (K0 14µM) (27) and this will probably hold true
=

as well for BCoV.

(ii) Regarding stem-loop III in BCoV, it has been shown that the

viral N protein and unidentified viral proteins of 22 and 38 kDa bind the stem-loop in the
positive strand and that seven cellular proteins in the molecular weight range of 76 and
25 kDa of unknown identity bind stem-loop III in the negative strand (Raman and Brian,
submitted). (iii) Regarding stem-loop IV in BCoV, it has been shown that eight cellular
proteins in the molecular weight range of 78 to 25 kDa of unknown identity bind the
stem-loop in the positive strand in a higher-order-dependent manner (31).

(iv)

Regarding stem-loop VI in the nsp 1 coding region of BCoV, it has been shown that p28,
the protein product of the nsp 1 coding region, binds to some region within this coding
region but it is not known whether it binds to stem-loop VI per se (Kortney Gustin,
unpublished data). (v) Regarding the bulged stem-loop and the pseudoknot in the 3'
untranslated region of MHV and BCoV, no protein has yet been shown to bind this
9

region (Agnieszka Dziduszko, unpublished data). . (vi) Regarding the GGAAGAGC
octameric region and the associated stem-loop, no protein has yet been shown to bind this
region except for the exciting new observation described below that the bovine
methyltransferase binds at or near the GGAAGAGC octamer (Agnieszka Dziduszko and
Tara Tucker, unpublished data). (vii) Regarding the 3'-terminal cis-acting poly(A) tail
in MHV and BCoV, it has been shown that the poly(A)-binding protein binds this region
(33).
It is our hypothesis that the cis-acting elements for bovine coronavirus genome
replication are binding targets for the enzymes used in genome replication. In that light, I
have, along with testing the enzyme activity of the BCoV 2'-O-MT (described below),
investigated its potential binding to the 5' untranslated region as a whole, and stem-loop
IV in particular. In collaboration with Kortney Gustin, its potential binding to the nsp 1
ORF and in collaboration with Agnieszka Dziduszko, its potential binding to the 3'proximal bulged stem-loop and adjacent pseudoknot, and the octamer-containing stem
loop, were also tested.

BCoV Replication Enzymes

Putative functions have been assigned to the cleavage products of ORF 1b based
on sequence homologies and motif similarities of known RdRP, Hel, ExoN, EndoN, and
MT enzymes (7, 32). Since these proteins are only translated when the ribosomal
frameshifting event occurs (about 20%-30% of the time in vitro), it is suggested that they
are needed in much less abundance than the other proteins encoded by the genome (39).
The replicase proteins are thought to assemble into a replication complex that is
10

associated with cellular membranes. Through the action of this complex, the viral
genome is replicated and the 3'-coterminal nested set of subgenomic mRNAs is made.
While it is presumed that the RdRP polymerizes nucleotides into RNA, the exact
functions of the Hel, ExoN, EndoN, and MT are not known. It is speculated that the
ExoN may be involved in RNA proofreading and repair functions but these would be
novel properties for an RNA virus; however, because of their large genomes, it's possible
they may have acquired this ability (39). The MT may be involved in 5' capping, a
process thought to increase mRNA stability and aid in ribosomal binding. The BCoV
helicase protein contains a putative N-terminal zinc-binding domain, a domain required
for helicase function.

RNA helicases unwind double-stranded RNA through the

hydrolysis of nucleoside triphosphates (39). The helicase may also participate in the 5'
capping reaction of viral mRNAs since it possesses a predicted 5'-triphosphatase activity
(23).

Rationale for a Focus on the Enzymatic and RNA Binding Properties of BCoV 2'-0Methyltransferase

The 2'-O-methyltransferase has been implicated in the capping reaction of the 5'
end of viral mRNAs, as was shown for an analogous flavivirus enzyme, the Dengue virus
NS5 protein (8). A conserved motif of amino acid residues present in the Dengue virus
2'-O-MT (NS5MTase0v), K61-D146-K181-E217, is also present in the BCoV 2'-O-MT,
K46-D130-Kl70-E203. Additionally, an analogous motif is also present in another 2'-O
MT, VP39 in the double-stranded DNA vaccinia virus, and is identified as K41-Dl38-
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Kl75-E207. These similarities led us to investigate the properties of the BCoV enzyme
further.
The binding pattern of the MT is of interest since it may suggest its site of action
and perhaps also other function(s). To study the binding capacity of the BCoV MT, the
electrophoretic mobility shift assay (EMSA) was used. By using RNA transcripts
containing the individual cis-acting elements from the 5' and 3' termini as radiolabeled
probes, the binding sites for the MT were sought.
The enzymatic function and binding capacity of BCoV MT have not yet been
demonstrated. We were therefore led to address the following questions. With regard to
enzymatic activity, will the MT transfer a methyl group from its donor, S -adenosyl-L
methionine (SAM), to a 5'-terminal RNA transcript produced in vitro? Will the MT bind
a potential RNA target with enough affinity and specificity to produce a gel shift in an
EMSA? What cis-acting replication elements are required for the binding of the MT to
BCoV RNA?
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CHAPTER II
CLONING OF THE BOVINE CORONAVIRUS RNA-DEPENDENT RNA
POLYMERASE, HELICASE, EXONUCLEASE, ENDONUCLEASE AND 2'-0METHYLTRANSFERASE GENES, AND EXPRESSION AND PURIFICATION
OF THE 2'-O-METHYLTRANSFERASE
Introduction

There are five genes in the BCoV genome that, on the basis of bioinformatic
predictions, encode enzymes for RNA metabolism and they are all located within ORF 1b
(32). These are, in order, the RNA-dependent RNA polymerase (RdRP), the Helicase
(Hel), the Exonuclease (ExoN), the Endonuclease (EndoN), and the 2 '-0Methyltransferase (MT). A required -1 ribosomal frameshift at the beginning of ORF 1b
enables the synthesis of the ORF 1b proteins, all made in less abundance than the proteins
of ORF la and in far less abundance than the (mostly) structural proteins made from
downstream ORFs by individually-produced subgenomic messenger RNAs.
The RdRP functions to replicate the genome and to synthesize subgenomic
mRNAs. The functions of the helicase, exonuclease, and endonuclea�e are not yet
known; however, the helicase may be responsible for unwinding secondary structure of
the RNA in order for it to be more accessible to the RdRP. The MT, based on analogy,
probably plays a role in 5' capping of the genome and subgenomic mRNAs, which helps
stabilize the mRNAs and aids in binding of the mRNAs to the ribosome. As a 2 '-0methyltransferase, its probable role is in catalyzing the transfer of a methyl group from
SAM to the first nucleotide 3' of the triphosphate bridge of the cap structure (8).
Each of the five BCoV replicase genes were cloned into the TOPO-XL vector
(Invitrogen) and subsequently into pGex (Amersham) and pET-28a (Novagen)
13

expression vectors to optimize chances for protein production. Additionally the MT was
cloned into pET-SUMO (Invitrogen). The long-term objectives were to express and
· purify each protein for enzyme function analyses, RNA binding analyses and ultimately
crystallization and structural analyses (the last goal is in collaboration with the laboratory
of Dr. Christopher Dealwis, Department of Biochemistry, University of Tennessee,
Knoxville). In addition, plasmids were sent to Proteintech Group, Inc. (Chicago, IL) for
the commercial production of rabbit polyclonal antiserum to each.

Three separate

expression vectors were used in this study in order to determine the optimal conditions
for protein expression. The pGex vector expresses a fusion protein with glutathione-S
transferase (GST), the pET-28a vector expresses a His-tagged fusion protein, and the
pET-SUMO vector yields a non-fused protein after protease cleavage from the SUMO
protein.

Materials and Methods
Virus and cells

Human rectal tumor (HRT) cells were infected with the bovine coronavirus
Mebus strain at an MOI of 1. HRT cells were grown as monolayers in Dulbecco's
modified Eagle medium containing 10% fetal bovine serum (Hyclone). At 6 hours post
infection, total RNA was harvested using TriZol (Invitrogen) and purified by phenol
chloroform extraction. cDNA for the RdRP was made by using reverse transcriptase and
the primer 3. l-268RL. For the Hel gene, primer 18302(+) was used, for the ExoN gene,
primer 19973(+) was used, for the EndoN gene, primer 21095(+) was used, and for the
MT gene, primer 21992(+) was used {Table II-1).
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Table 11-1 . Oligonucleotides used in this study.
Oligonucleotidea

3 . l-268RL(+)

Sequence0

GCCAGTTGCCTTATATTTG

Binding
Region (nt
positiont

179961 8014
18302(+)
GCTGTAACCATCTCTATCAGCAAAC
1 82781 8302
1 9973(+)
TGTGTCTCCAACCTTGTCCA
1 9934CCACTACGCC
19973
21095(+)
AACACTGCCACCCAGAGCTAAC
2107421095
21992(+)
TGAGGGGTTGATAGTGATTTTATAATTG
2196521992
BamRdRP(-)
CGGGATCCTCAAAAGATACTAA
133 1 8TTTTTTTAAACGGGTTCGGGG
13351
PstlRdRPStop(+) CGGCTGCAGTCATCATCACTGCATAAC
16067TGCACTTCTTAAATACATGTTCTTG
16100
BamHel5(-)
CGGGATCCAGTGTTGGAGC
16101TTGCGTGGTCTGCTC
16126
17882EcoRIHelStop(+) CGGAATTCTCATCATCATTGAACT
CTCGTTTCAACGGCCTGTGGC
17909
CGGGATCCTGTAGTACCAATTTATTTA
17910BamExo5(-)
17934
AAGATTGTAGCAAGAG
19472EcoRIExoStop(+) CGGAATTCTCATCATCATTGTAGC
TTGGTGAACGTATTCCCAC
19449
19473CGGGATCCAGCTTGGAGA
BamEndo5(-)
ATGTTGTATATAA
1 9495
CGGAATTCTCATCATCATTGCAAA
20574EcoRIEndoStop(+)
20594
CGAGGATAGAAAGTC
20595CGGGATCCGCTGCATCTGACTGGA
BamMT5(-)
20617
AGCCTGG
21465CGCAATTGTCATCAGATTACATTAAC
MfeMTStop(+)
CATACTGTCACCAAC
21491
aOligonucleotide binds to either plus-sense RNA as indicated by (+), or to minus-sense
RNA as indicated by (-).
1underlined bases indicate differences from genomic sequence.
cNumbers correspond to Bovine Coronavirus-Mebus strain genome sequence.
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Cloning into TOPO-XL plasmid vector

The TOPO-XL vector (Invitrogen) was designed to facilitate the cloning of PCR
products since it takes advantage of the extra terminal 3' deoxyadenosine residue added
by the Taq polymerase during PCR. For cloning, cDNAs were used as templates in PCR
reactions with Taqmaster polymerase (Eppendorf) along with the appropriate primers to
amplify each gene {Table 11-1). The primers used were engineered to contain restriction
enzyme sites at the 5' and 3' ends to aid in cloning, and stop codons at the 3' ends to aid
in protein expression. For ExoN and EndoN clones, a BamH I site was engineered at the
5' end and an EcoR I site at the 3' end. Additionally, three stop codons were engineered
into each 3' primer. This was necessary since the genes are expressed naturally as
internal segments of a polyprotein subsequently cleaved into individual functional
proteins by ORF la-encoded proteases. Primers used to amplify the ExoN gene were
BamExo5 and EcoRIExoStop. Primers used to amplify the EndoN gene were BamEndo5
and EcoRIEndoStop. To clone the 2'-0-MT, the 5' primer contained a BamH I site and
the 3' primer a stop codon and an Mfe I site, as the sequence of the gene already
contained an EcoR I site. The primers used were BamMT5 and MfeMTStop. Digestion
with Mfe I and EcoR I produce compatable sticky ends so the Mfe I-digested 2'-0-MT
gene ligates readily into an EcoR I-digested vector. To clone the RdRP, PCR was
performed using primers BamRdRP(-) and PstIRdRPStop, and for the Hel, primers
BamHel5 (-) and EcoRIHelStop were used.

An extra T was designed into the -1

frameshift of the RdRP 5' primer to ensure a correct reading frame for the gene. Each
PCR reaction product was purified by electrophoresis in a crystal violet-containing
agarose gel (Invitrogen), and each product was ligated into the TOPO-XL vector using
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the recommended procedure of the supplier (Invitrogen). The ligation mixtures were
transformed into TOPl0 eliectrocompetent cells and cells were plated on 2XYT agar
°
plates in the presence of kanamycin and grown overnight at 37 C.

Colonies were

screened by PCR using primers that bound within the cloned gene and positive colonies
were used to make plasmid minipreparations with the Wizard Miniprep system
(Promega). Sequences of cloned genes were determined by automated DNA sequencing
in the Molecular Biology Resource Facility at the University of Tennessee.

Cloning into expression vectors
Three of the replicase enzymes, ExoN, EndoN, and MT, were cloned into
expression vectors. The RdRp and Helicase genes in the TOPO-XL vector contained
unwanted point mutations that were not easily repaired by repeated cloning so these were
not used futher. For the ExoN and EndoN, 10µ1 of each respective TOPO-XL plasmid
minipreparation was double-digested with BamH I and EcoR I at 37 C for two hours.
°

The digested products were then resolved by electrophoresis on a 1% agarose ethidium
bromide gel and products isolated with the Geneclean III kit (Q·Biogene). Expression
vectors, pGex and pET-28a, were also double-digested with BamH I and EcoR I and the
products dephosphorylated with calf intestinal phosphatase (New England Biolabs),
resolved by electrophoresis in a 1 % agarose ethidium bromide gel, and isolated with the
Geneclean III kit (Q·Biogene). The purified linearized dephosphorylated vectors and
purified digested gene products were ligated as required using the Quick Ligase kit (New
England Biolabs). Ligated products were transformed into chemically competent DH5a
cells (Invitrogen) and 100µ1 of each transformation reaction mixture was plated onto
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2XYT agar plates containing ampicillin in the case of the pGex constructs and containing
kanamycin in the case of the pET-28a constructs, and plates were incubated overnight at
37° C. Colonies were screened by PCR and positive colonies were used to make plasmid
minipreparations which were then sequenced to verify a wild-type sequence in the clone.
The MT gene was similarly cloned into pGex and pET-28a vectors except that
Mfe I replaced EcoR I for digestion of the MT-TOPO-XL plasmid minipreparation.
Vectors were linearized with BamH I and EcoR I and ligation, transformation, plating,
screening, and sequencing procedures were as described above.
Additionally, the MT gene was cloned into pET-SUMO to produce a product with
no extraneous fusion sequence following the SUMO protease cleavage step. For this, a
5' primer that corresponds to the precise 5' end of the MT gene (i.e., without a restriction
endonuclease site) was used. The 3' primer contained two sequential stop codons. The
PCR product was isolated using Q·Biogene's Geneclean III kit and ligated into the pET
SUMO vector following the protocol of the manufacturer (Invitrogen). The ligation
mixture was transformed into One Shot Machl -Tl chemically competent E. coli cells
(Invitrogen) and 100µ1 of the transformation reaction mixture per plate was spread on
2XYT agar plates containing kanamycin. Screening and sequencing procedures were
carried out as described above.

Bacterial expression and purification of cloned BCoV 2'-0-Methyltransferase
MT was expressed from pGex-MT as a GST fusion protein, and from pET-28a
MT as a his-tagged MT in order to increase the chances of getting efficient protein
expression. For expression from pGex-MT, plasmid DNA was transformed into BL2 1
18

pLysS E. coli cells and grown in TB medium with ampicillin and chloramphenicol.
Expression was induced with IPTG at 15 C overnight. Cells were lysed and proteins in
°

the lysate bound to glutathione-sepharose resin (Amersham Biosciences) by incubation
for two hours and end-over-end rotation. The column was washed sequentially with
thrombin wash buffer (50mM Tris pH 8.0, 200mM NaCl, 5% glycerol), high salt buffer
(50 mM Tris pH 8.0, 0.5 M NaCl), CHAPS buffer (50mM Tris pH 8.0, 200mM NaCl,
8mM CHAPS), and then standard wash buffer to remove salt and CHAPS. Thrombin
was added to the column and the mixture incubated at room temperature for 2 hours with
occasional rotation. The flowthrough was collected and the resin washed with thrombin
wash buffer to collect any remaining protein. The eluate was subjected to Superdex75
column chromatography to increase protein purity.
For expression from pET-28a-MT, plasmid DNA was transformed into BL21
pLysS E. coli cells and grown in TB with chloramphenicol and kanamycin. Expression
was induced with IPTG and grown for 15 hours at 15 C, and cells were pelleted and flash
°

frozen in liquid nitrogen. Thawed cells were resuspended in lysis buffer (50mM Tris pH
8.0, l OOmM NaCl, lmM EDTA, 10% glycerol, 5mM DTT, l mM PMSF, 1ul Benzonase
per 10g cells) and the lysate was clarified by centrifugation for one hour. Lysate was
incubated with NiNTA resin (Qiagen) at 4 ° C for one hour on an orbital shaker. The
lysate-resin mixture was poured into an EconoColumn and flowthrough collected. The
column was washed with -50 column volumes of wash buffer and thrombin was added at
a concentration of -5µL per liter of cells. The reaction mixture was incubated at room
temperature for one hour with gentle agitation every few minutes, after which the
19

flowthrough plus two column volumes of wash were collected. The MT contained in the
flowthrough was purified on a Superdex75 size exclusion column.

Synthetic oligonucleotides used in this study

Oligonucleotides used in this study are described in Table 11-1.

All

oligonucleotides were synthesized by Invitrogen Life Sciences (Carlsbad, CA).

Results
Cloning of the BCoV RNA-dependent RNA polymerase, Helicase, Exonuclease,
Endonuclease, and 2'-0-Methyltransferase genes into the TOPO-XL vector

The procedures used for cloning the five replicase genes into the TOPO-XL
vector are described in Materials and Methods. Figure 11-1, A illustrates the PCR
products of the ExoN, EndoN and MT genes resolved by agarose gel electrophoresis
prior to cloning into the TOPO-XL vector. The sequences of the cloned RdRp and Hel
genes showed them to have point mutations at various sites throughout. cDNA cloning
of each was repeated several times but wt sequences were not found and thus cloning into
expression vectors was not pursued at this time. The sequences of the cloned ExoN,
EndoN and 2'-0-MT genes, however, were wt and were futher cloned into expression
plasmid vectors of E. coli.
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Figure 11-1. Cloning the BCoV replication enzymes. A. PCR products of the
ExoN, EndoN, and MT genes from a cDNA template. The numbers beside the bands
indicate the size of the PCR product in kilobase pairs including the stop codons and
restriction enzyme sites that were designed into the primers. B. PCR screen of the 2' -O
MT cloned into the pET-28a vector. Lane 1, + control (l µl of the ligation mixture); Lanes
1, 2, 4, 9, 11, and 12, colonies positive for the 2' -O-MT gene; Lanes 3, 5-8, 10, 13 and
14, colonies with no insert.
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Cloning of the BCoV Exonuclease, Endonuclease, and 2'-0-Methyltransferase genes
into expression vectors

Many colonies screening positive for the ExoN, EndoN and 2'-0-MT genes were
found to contain wt gene sequences and some of these were used as sources for cloning
into expression vectors. Mini-prepped plasmid DNA preparations were digested with
restriction endonucleases corresponding to the engineered sites and inserts, purified by
electrophoresis on a 1% agarose ethidium bromide gel, were ligated into appropriately
linearized and dephosphorylated expression vectors that were used to transform
chemically competent DH5a cells. Resulting colonies were screened by PCR for inserts
of the proper size as depicted in Figure 11-1, B. The MT was cloned into the pET-28a and
pGex vectors forming pET-28a-MT and pGex-MT, respectively, and subsequently cloned
into pET-SUMO forming pET-SUMO-MT. The ExoN and EndoN were cloned into
pET-28a and pGex (data not shown).

Expression and purification of the 2'-0-Methyltransferase

For the purposes of measuring enzyme activity (Chapter III) and RNA binding
(Chapter IV), the MT expressed from pGex-MT was used since the yield from this vector
was the best. Figure 11-2 illustrates the MT protein as a fusion protein with GST and the
intervening amino acids. Attempts to cleave off the MT from the GST protein with 3C
protease (which cleaves immediately adjacent to the MT) to yield a native MT protein
were unsuccessful. Therefore, cleavage with thrombin was used although this approach
left an additional 11 N-terminal amino acids on the MT which could possibly interfere
with either enzyme function or RNA binding. A colony screening to find positively
22

Thrombin
Cleavage Site

GST

2 1 8 aa
MW: 26 kDa

-SDLVXR_GSEVLFQGPGS-

BCoV
2'-0-MT
299 aa
MW: 35 kDa

Figure 11-2. OST-Fusion construct showing the fusion protein produced when the
MT is expressed from the pGex vector (pGex-MT). The arrow indicates the site at which
the protease, thrombin, cleaves GST from the target protein. The amino acids to the right
of the cleavage site in the diagram remain attached to the released MT.

23

transformed bacteria is illustrated in Figure II-3, A. After confirming expression of an
induced fusion protein, cells were lysed and the fusion protein purified by affinity
chromatography. MT was cleaved from the fusion protein and collected. Samples of the
eluate were resolved by polyacrylamide gel electrophoresis to determine location of the
protein (Figure II-3, B). A sample from the column resin eluted by SOS-PAGE sample
treatment buffer was also resolved by polyacrylamide gel elctrophoresis to determine the
degree of MT column retention. The presence of a 35 kDa band in the sample containing
the eluate collected after the thrombin cleavage indicated that the MT was expressed in
the cells and collected. However, presence of the 35 kDa band in the sample containing
the resin indicated that not all of the protein was eluted in the initial step following
thrombin cleavage. A -26 kDa faint band is also present in the sample of the MT eluate
indicating that some GST impurities may be present. Expression of the MT from the
pET-28a vector was performed (data not shown). In this case, however, expression
levels were poor and the purity of the protein was low.

Discussion

The principal complication in cloning the five replicase genes from ORF 1b of BCoV
was the occurrence of random point mutations in the resulting clones. Random mutations
were most prominently found in the constructs of the RdRP and Hel genes. Wild-type
clones of the ExoN, EndoN, and MT genes in expression vectors were ultimately
obtained. PCR mutagenesis reactions were performed on clones of the RdRP in attempts
to repair single point mutations, but in these attempts alternate point mutations were
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Figure 11-3. Expression of the BCoV MT from pGex-MT. A. Colony screen of
cell colonies transformed with fusion protein-containing plasmid. The fusion protein has
a molecular weight of-60kDa. Lane 3, indicated by the arrow, represents the colony with
the best expression of the fusion protein. B. SOS-PAGE gel containing a sample of the
eluate after the thrombin cleavage (lane 1) and material retained on the resin from the
column (lane 2). Arrows indicate the location of the bands representing the MT and
OST. The MT is -35kDa and OST is -26kDa.
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found. Since the point mutations were random and varied in position it is believed they
were introduced at a step subsequent to PCR, possibly during selection in the transformed
cells.

It

is postulated that the RdRp and Hel enzymes contain sequences toxic in some

fashion to the E. coli host and that non-toxic variants are selected by the host. The BCo V
2'-O-MT gene was cloned into pGex and used to express the MT as a fusion protein with
GST.

The 2'-O-MT was cleaved from the GST protein and used in subsequent

experiments which will be discussed in detail later.

There were initial expression
°

problems with the protein. (i) Whereas induction at 37 C for 3 hours showed poor
expression, induction at 15 ° C for 20 hours showed much better expression (data not
shown). (ii) Whereas much 35kDa protein was retained on the resin after washing with

normal elution buffer, post-cleavage elution with CHAPS buffer proved much better
(data not shown). (iii) The presence of a 26kDa band in the eluate lane (Figure 11-3, B)

indicated that some GST, which should remain on the column, had eluted with the MT.
(iv) Initially we expected to use the 3C protease site just N-terminal to the start of the
MT protein to cleave MT from the GST protein. However, cleavage efficiency of this
construct on the column was extremely low. · It was then postulated that perhaps the GST
and 2'-O-MT domains of the fusion protein were interacting a way that blocks access of
the protease to its cleavage site, and thrombin was chosen to make the cleavage.
Although this enzyme leaves extra amino acids at the N-terminus of MT, once optimized
the protocol yielded milligram quantities of the protein used for further experimentation
as described in Chapters III and IV.
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CHAPTER III
ASSAY FOR THE ENZYMATIC ACTIVITY OF BACTERIALLY
EXPRESSED BOVINE CORONAVIRUS 2 '-O-METHYLTRANSFERASE
Introduction

The 2'-O-Methyltransferase gene in the coronavirus genome has only recently
been identified, and this was based on bioinformatic analyses (32). No functional or
structural studies on a coronavirus MT have been published to date and it is toward this
end that we have initiated studies on the bovine coronavirus MT.
Many viruses that replicate in the cytoplasm encode their own MT, presumably to
enable them to methylate their own translation-enhancing 5 '-terminal cap structures that
would be otherwise out of reach of the cellular methyltransferases that function in the
nucleus. The viral MTs also may have evolved other viral-specific functions required for
virus replication. It is quite possible that a viral MT would methylate internal bases on
the genome that would serve as some kind of heretofore uncharacterized signal for RNA
function, or it could possibly methylate an amino acid to carry out another kind of
signaling event. Viral MTs are thought to be attractive targets for chemotherapy since
they have structural and biochemical features differing from cellular MTs. For this
reason a detailed study of the BCoV MT activity to determine its function was
undertaken. A description of our analyses follows.
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Materials and Methods

In vitro synthesis of three potential target RNAs for the in vitro methylation assay
For assays of the BCoV MT activity, it was presumed that the most likely targets
for methylation would be an unmethylated G(5')ppp(5')G cap structure at the natural 5'
end of the genome (which by virtue of the common leader strategy of coronavirus
transcription is also the 5' terminus of the subgenomic mRNAs ), and a partially
methylated cap structure, m7G(5')ppp(5')G. However, a terminus with no cap at all was
also possible, so a 5'-terminal target with no cap was also made and tested. To obtain
these, a cloned BCoV defective interfering (DI) RNA of the BCoV under control of the
T7 RNA polymerase promoter was used in an in vitro transcription reaction to make the
capped and uncapped target RNA. Construction of the DI RNA-containing plasmid,
pDrepl , has been previously described (6). pDrepl , constructed in the pGEM-3Zf(-)
(Promega) backbone, was linearized at the Hpa I site at genomic nt 1 52 by overnight
digestion at 37· C. The linearized plasmid was isolated using the DNA Clean and
Concentrator-5 kit (Zymo Research) and used in an in vitro T7 RNA polymerase
transcription reaction with RiboMax Large Scale RNA Production System (Promega).
To produce a transcript with a totally unmethylated cap structure, G(5')ppp(5')G (New
England Biolab) was used in the reaction mixture, and for a partially methylated cap,
Ribo 7m cap analog (Promega) was used in the reaction mixture, and for a 5' structure
with no cap at all, nothing was added.
5'GAUUGUG...

In this last case the 5' terminus was

In vitro RNA transcripts were phenol/chloroform extracted and

purified by chromatography through a Bio-Spin 6 column (Bio-Rad) to remove
unincorporated nucleotides, and ethanol precipitated.
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In vitro assay for BCoV 2'-O-Methyltransferase enzyme activity

For the in vitro assay for 2'-O-Methyltransferase enzyme activity, the method of
Egloff et al (8) was used. Unmethylated capped, partially-methylated capped, and
uncapped RNA transcripts were added to reaction mixtures at 19µM with 40mM Tris
HCI, 100µM AdoMet with 10µCi Ado[ methyl-3H]Met 85Ci/mmole, 5 µg purified 2 '-0MT, 5% glycerol, and lmM DTT. 8µ1 aliquots of each sample and aliquots of a control
reaction containing no RNA were removed at time points 0, 10, 20, 60, 120, 180, 240,
300, and 350 minutes, mixed with 10µ1 of lO0µg/ml BSA and 5% glycerol, and the entire
18µ1 was spotted onto a pre-wetted Whatman DEAE-81 paper disc. The paper discs were
washed sequentially with four 1ml volumes of 200 mM ammonium bicarbonate, four 1ml
volumes of water, and four 1ml volumes of ethanol, air dried, and tritium incorporation
was determined by liquid scintillation counting.

Results
Comparative analysis of the BCoV 2'-0-Methyltransferase with other
methyltransferases

By comparison with other MTs, the BCoV MT appears to be a member of the
RrmJ family of MTs and shares a common structural fold with other viral MTs such as
VP39 from vaccinia virus (25), a cytoplasmic DNA virus, and NS5MTov from Dengue
virus, a cytoplasmic positive-stranded RNA virus (8) (Table III-1 ). The BCoV MT is a
protein of about 35 kDa and contains a predicted pocket for the binding of SAM, the
methyl group donor in the methyl transfer reaction in the capping process.
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Table 111-1. Characteristics of viral methyltransferases. Activity has not been
established for each of these enzymes. Sequence analysis predicts the activity indicated.
Putative SAM binding/active
site indicates the catalytic region based on sequence and
.
ammo
. ac1'd compansons w1'th ana1ogous s1·1es m
. other MT enzymes.
Protein
Name

Organism

Methyl
Donor

Reaction

Putative
SAM
Binding/
Active
Site

Comments

Ref.

A2

Reovirus

Guanosine-7-N
MT; 2'-0-MT

SAM

Residues
825-888

Both MT
activities
observed in
Reovirus
cores

(26)

NS5

Dengue

2'-0-MT

SAM

Bamboo
Mosaic
Virus

GTP methyltransferase;
Guanylyltransferase

SAM

MT at Nterminal
domain of
RdRP
GTP moiety
methylated
before
transfer to

(8)

155 kDa
polypeptide

Cleft
between �
strands 1
and 4
N terminal
442 amino
acids

VP39
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There are three general steps in the capping process (8). In the first, an RNA
triphosphatase converts the 5'-triphosphate of the mRNA to a diphosphate. In the second
step, a guanosine · monophosphate (GMP) moiety is transferred from guanosine
triphosphate (GTP) to the 5'-diphosphate RNA by a guanylyltransferase. In the third
step, the reaction consists of methylating the transferred guanosine moiety by a guanine
N7-methyltransferase by the use of SAM as a methyl donor. In a second methylation
reaction, the first nucleotide 3' to the triphosphate bridge is methylated by a nucleoside2'-0-methyltransferase. Adjacent nucleotides located 3' to the first methylated base may
also be methylated and the order of the reactions may vary. The BCoV MT is thought to
function in the last of these steps in which a methyl group is transferred to the first
transcribed nucleotide of the mRNA.
Various assays have been developed to measure viral methyltransferase activity.
Experiments using the negative-strand RNA Sendai virus show that L protein, which has
RNA-dependent RNA polymerase activity, catalyzes guanosine methylation of virus
specific mRNA. Sequence analysis of the C-terminus of this protein also suggests a
possible 2'-0-MT domain (28). In another example, VP39 from the double-stranded
DNA vaccinia virus is the sole structurally characterized viral methyltransferase that is
known to have 2'-0-methyltransferase activity (2).

We chose to use the

methyltransferase assay conditions of Egloff et al (8) employed in a study of Dengue
virus (flavivirus) MT since the BCoV MT has bioinformatics-predicted similarities in
structure and function (11). The Dengue virus MT, NS5, is part of a multifunctional
protein wherein the MT domain is at the N-terminus and the RdRP domain is at the C
terminus.

In the Egloff assay, short potential acceptor RNA transcripts were either
31

capped, had a partially methylated cap (in which the transferred GMP is methylated), or
were uncapped, and tritiated SAM was used as the methyl donor. In the Dengue virus
MT assay, the capped and partially methylated capped transcripts were better acceptors
for methylation by the 2'-0-Methyltransferase than the uncapped transcripts (8). This
fits with the notion that the Dengue virus NS5 protein is a 2'-0-Methyltransferase,
participating in a reaction which transfers a methyl group to the first transcribed
nucleotide of the mRNA.
To produce target RNA for methylation in our assay, pDrepl was linearized at the
Hpa I site at nt 1 52 and used as a template for T7 RNA polymerase-driven in vitro

transcription. pDrepl contains the entire 5'- and 3'-UTRs, a portion of ORF la encoding
protein p28, and the entire N gene fused in-frame to make a single long open reading
frame.

RNA transcripts were 5'-terminally capped, uncapped or contained an

unmethylated cap. Tritium-labeled SAM served as the methyl donor and purified BCoV
MT was the enzyme source. The abundance of tritium incorporation was the measure of
MT activity.
The BCoV 2'-0-Methyltransferase did not methylate RNA transcripts

When tritium incorporation was measured for capped, uncapped, and
unmethylated capped transcripts, no evidence of RNA methylation was found (Figure 1111). One major peak was observed for the unmethylated capped RNA at ,...,15 minutes, but
it was similar to a peak in the negative control at -210 minutes so the results were judged
to be inconclusive.
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Figure III-1. Tritium incorporation of RNA transcripts. This graph shows tritium
incorporation of capped, uncapped, and unmethylated capped RNA transcripts plus a
negative control over a 350 minute time period. Tritium incorporation was measured by
liquid scintillation counting. Five readings were taken for each sample; the highest and
lowest values were discarded and the remaining 3 values were averaged to generate the
graphs.
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Discussion

Our results from the functional assay for BCoV 2'-O-MT activity indicate that
the enzyme was not active under the conditions tested. One problem with the assay was
the lack of a reliable level for the negative control. The negative control values should
have been at background levels (around 400-500 cpm) (8) but were consistently 500 cpm
and higher. This indicates that the values for the sample RNA transcripts are not reliable
apparently because some of the unincorporated 3H-SAM was not getting washed away.
Also, one explanation for the apparent inactivity of the enzyme in this assay is that the
BCoV 2'-O-MT may not function as an individual protein but as a polyprotein or as a
membrane-bound protein complex with the other replication enzymes.

Many viral

proteins that function as enzymes from positive-strand RNA viruses carry out their
enzymatic function as a protein precursor of the final digested product. For example,
poliovirus protein CD is a precursor to the final digested products, C (a protease) and D
(the RdRp ). The protease functions only as a precursor CD molecule. If this is the case
with the BCoV MT, using purified recombinant protein alone would not support the
function of the enzyme and, therefore, would not allow for measurable methylation of
RNA transcripts.
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CHAPTER IV
BACTERIALLY-EXPRESSED BOVINE CORONAVIRUS 2'-0METHYLTRANSFERASE BINDS C/S-ACTING STEM-LOOP IV IN THE
5' UNTRANSLATED REGION OF THE VIRAL GENOME
Introduction

In Chapter I are described six cis-acting elements for BCoV genome replication as
determined through a study of the 2.2 kilobase BCoV DI RNA. These are summarized in
Fig. I-3. Potentially these elements act as binding sites for the replication enzymes
encoded in ORF 1b or other viral proteins involved in RNA replication. Alternatively,
they could provide an assembly focus for one enzyme that then binds others
cooperatively in the formation of a replication complex, which in tum leads to replication
of the genome and the antigenome. For example, it has been shown that the nucleocapsid
(N) protein binds stem loop III of the 5' UTR (Raman, submitted).
In this study we were interested in exploring potential interactions between the
BCoV 2'-0-MT and cis-acting replication elements in the 5' UTR of the BCoV genome.
For this, a series of electrophoretic mobility shift assays (EMSA) using probes
representing three cis-acting elements in the 5' UTR were used. The absence of the MT
binding to two other regions of the genome known to contain cis-acting elements, namely
(i) the region of the genome encoding nsp 1, and (ii) the bulged stem-loop and adjacent
pseudoknot in the 5'-proximal region of the 3' UTR, served as negative controls for
protein binding. The assays for the MT binding to the nsp 1 region and the bulged stem
loop and adjacent pseudoknot were done collaboratively with Kortney Gustin and
Agnieszka Dziduszko, respectively. It was observed that the BCoV MT binds stem-loop
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IV. This is the first report of an RNA-protein interaction for a coronavirus-encoded
methyltransferase.

Materials and Methods
Construction of plasmids

Construction of plasmid p225 was accomplished by using primers p225Eco (5'GAATTCGATTGTGAGCGATTTGCGTGCGTGCATTC-3')

and

Hind225(+)

(5'

AAGCTTGTTGATCTTCGACATTGTGACCTAT-3') in a PCR reaction with pDrepl as
a template to generate a PCR amplicon of the first 225 nucleotides of the BCoV genome.
The p225Eco (5') primer was designed to have an EcoR I site, and the Hind225(+) (3')
primer was designed to have a Hind III site. The PCR product was isolated from the gel
with the use of Q·Biogene's GeneClean III kit. The isolated product was cloned into
TOPO-XL and transformed into TOPlO electrocompetent cells (Invitrogen). Cells were
plated onto plates containing 2XYT agar and kanamycin and grown overnight at 37 ° C.
A PCR screen was done to determine the colonies positive for the plasmid, and
sequencing was carried out at the UTK Molecular Biology Resource Facility to verify
that the inserted sequence was wild-type. A minipreparation was made from a colony
containing the wild-type plasmid using Promega's Wizard Miniprep kit. This miniprep
was used in a double digestion reaction with EcoR I and Hind III. The digested insert
was isolated from a 1% agarose ethidium bromide gel by GeneClean and cloned into the
vector pGEM-3Zf(-) (Promega). Construction of the plasmid pSLIV has been previously
described (31 ). pSLIV is a plasmid containing the 30-nt stem-loop IV region and flanking
sequence on both the 5' and 3' ends, contained in the vector pGEM-3Zf(-).
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Production of antibodies to the BCoV 2'-0-Methyltransferase

pGex-MT was used by the Proteintech Group, Inc. (Chicago IL) for commercial
production of rabbit polyclonal antibodies to BCoV 2'-O-MT. We have received both
preimmune and immune serum preparations as well as 1 mg of affinity column-purified
fusion protein of BCoV 2'-O-MT from Proteintech.

In vitro transcription

The plasmid p225 was linearized with Hind III in an overnight reaction at
37 ° C. The plasmid pSLIV was linearized using Nco I in an overnight reaction at 37 ° C.
The linearized DNA was isolated using DNA Clean and Concentrator-5 from Zymo
Research. The isolated DNA was added to a 50µ1 in vitro transcription reaction mixture
to make a final concentration of 2.5µg per reaction, with 10µ1 5X transcription buffer,
5µ1 lO0mM DTT, 2.5µ1 acetylated BSA (2mg/ml), l µl RNasin (40U/ul), 10µ1 rGTP
(2.5mM), 10µ1 rATP (2.5mM), 10µ1 rCTP (2.5mM), 3µ1 rUTP (200µM), 12µ1 a 32 P
UTP, and lµl T7 polymerase. The reaction mixture was incubated at 37 ° C for 1 hour, at
which time 2.5 µl RQl RNase-free DNase was added, and the reaction incubated for an
additional 30 minutes at 37 ° C. 50µ1 sequencing stop dye was added to the reaction and
the entire reaction mix was electrophoretically resolved on

a denaturing

urea/polyacrylamide gel at 200 volts constant voltage. The gel was exposed to film for
10 minutes and the isolated probes were cut directly from the gel and eluted overnight on
a rotary tumbler at 4 ° C in 0.5M ammonium acetate and lmM EDTA. The eluted probes
were ethanol precipitated and resuspended in 20µ1 of water. The radioactive content of
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the probes was measured by Cerenkov counting and the probes diluted to 1-2 X 104
cpm/ul.

Protein binding assays

For protein binding, essentially the conditions of Thomson (35) were used, but
with the addition of yeast tRNA (16) and heparin (3). To 20 µl of a mixture of 5mM
HEPES, 40mM KCl, 2mM MgCli, 4% glycerol, 2mM DTT, yeast tRNA (1 µg/µl),
heparin (0.25 µg/µl), PMSF (lX), and RNasin inhibitor (20U/µl) was added 0.35 to 5 µg
°

of purified MT protein and the reaction was incubated at 37 C for 10 minutes. The yeast
tRNA was added as a non-specific competitive inhibitor. To certain reactions, 5 to 15µg
of cold competitor RNA was added, and the reactions were incubated for an additional 10
°

minutes at 37 C. To this mixture was added l µl of radioactive probe and the reaction
mixture was incubated at 37 ° C for 10 minutes.

Electrophoretic mobility shift assays

For electrophoretic separation of RNA-protein complexes, 2 µ1 of 50% glycerol
was added to the probe-protein mixture and electrophoresis was carried out on a native
gel of 5% polyacrylamide-5% glycerol for the stem-loop IV construct and 4%
polyacrylamide-5% glycerol for the p225 construct at 4 ° C with 0.5 x TBE running buffer
(1 x TBE= 90 mM Tris HCl, 90 mM boric acid, 2 mM EDTA) for approximately 4 h at
100 volts constant voltage.
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Results
The Bovine Coronavirus 2'-0-Methyltransferase binds stem-loop IV of the 5'
untranslated region of the genome

To investigate the binding properties of the MT, a series of gel shift assays were
performed using the purified MT and radiolabeled probes encompassing the entire 5'
UTR (p225) or only stem-loop IV (pSLIV) (Figure IV-1). In the first assay, the binding
of the MT to a 225-nt long 32 P-UTP labeled probe, a probe encompassing the first 225 nts
of the BCoV genome which included the 210-nt 5' UTR and 15 adjacent nts, was done,
and it was observed that this interaction produced a shift, even in the presence of yeast
tRNA, a non-specific competitive inhibitor (Figure IV-2, A).
To begin to address the question of which specific elements, if any, within the 5'
UTR the MT might be binding, the probe encompassing only stem-loop IV and
synthesized from pSLIV (Fig. IV-1 B) was used. This construct contains the 30-nt stem
loop IV flanked by 36 nts upstream and 47 nts downstream. For this experiment, the
pSLIV plasmid was linearized at the Nco I site at genomic nt 262, producing a 113-nt
transcript upon in vitro transcription. The radiolabeled probe was incubated with MT and
the reaction was resolved by polyacrylamide gel electrophoresis on a non-denaturing gel.
The results shown in Fig. IV-2, D and E demonstrate that the MT binds stem-loop IV
with enough affinity to cause a retardation of electrophoretic migration, a gel shift.
A probe representing the nsp 1 coding region, made by Kortney Gustin (probe P1
in Fig. IV-2, B), and a probe representing the bulged stem-loop and adjacent pseudoknot
in the 3' UTR, made by Agnieszka Dziduszko (probe PK in Fig. IV-2, C), did not bind
the MT. This is illustrated by the absence of a gel shift with the MT in Figure IV-2, B
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Figure IV-1. Structure of the probes used in the EMSAs. A. p225 probe made by
T7 RNA polymerase after linearizing plasmid p225 at the Hind III site. B. pSLIV probe
made by T7 RNA polymerase after linearizing plasmid pSLIV at the Nco I site. Numbers
at the bottom of the figure indicate genomic nucleotide position.
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Figure IV-2. Gel shift assays. A. Assay with probe p225. Lanes 1 and 6, free
probe; lane 2, p225 with 5µg MT; lanes 3, 4, and 5, with 5, 10, and 15µg of cold
competitor RNA, respectively; lanes 7, 8, 9, 10, 11, 12, with 0, 5, 10, 15, 20, and 25µg of
yeast tRNA, respectively. B. Assay with probe P l , containing stem-loops V and VI. Lane
1, free probe; lane 2, with 1: 1000 ratio of probe to protein. C. Assay with probe PK,
containing the 5' proximal pseudoknot of the 3' UTR. Lane 1, free probe; lane 2, with
1: 100 ratio of probe to protein. D. Competition assay with pSLIV probe. Lanes 1 and 4,
free probe; lanes 2 and 3, with 5 and l Oµg of cold competitor RNA, respectively. Lanes
5, 6, 7, and 8, with 2.5, 5, 10, and 20µg tRNA, respectively. E. Assay with pSLIV probe.
Lane 1, free probe; Lanes 2, 3, 4, 5, with 0.35, 1.75, 3.5, and 5µg of MT, respectively.
tRNA was used as a non-specific competitive inhibitor. Unless otherwise indicated, all
lanes contain 5µg MT and 20µg tRNA.
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and C. P l is a 134-nt probe containing stem-loops V and VI, and PK is a 147-nt probe
containing the 5'-proximal bulged stem-loop and adjacent pseudoknot in the 3' UTR.

Discussion

The results of the electrophoretic mobility shift assays performed here indicate
that the BCoV 2'-O-Methyltransferase binds within the 5' UTR of the genome, and that
at least one of the elements responsible for the binding within this region is stem-loop N.
The binding of the MT to an element in the 5' UTR of the genome is not unexpected
since it is predicted to function in the capping of the genome and subgenomic mRNAs,
and these occur at the genome 5' terminus. Many questions need yet to be answered
about the BCoV MT concerning its function. What does it do? Does it, in fact, act to
methylate the cap structure, or might it methylate at other sites? For example, does it
methylate bases internally within the genome that might serve as signals for other
processes? It is still not clear what signals the RdRp to template switch at internal sites in
order to place a leader onto sg mRNAs (20, 29). Conceivably, a methyl group might
signal such a template switch. Does the MT per chance methylate a viral protein and
hence regulate its function?
In a separate set of experiments performed by Agnieszka Dziduszko with the MT
described in this study, it was found that the MT binds a region near the 3' end of the
genome.

Preliminary data suggest it binds at or near the octameric sequence,

GGAAGAGC, found universally in coroanvirus genomes at approximately 70 nts in from
the 3' end of the genome. Mutations in the octameric sequence destroy the replicating
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ability of the BCoV DI RNA, pDrep1 (Hung-Yi Wu, unpublished), suggesting it has
importance as a replication signal. Perhaps the binding of the MT to the 3' end of the
genome is involved in genome cyclization, a postulated requirement for replication of
many positive-stranded RNA viruses (1, 14, 15, 19, 38).
Ultimately it will be important to determine where, within the BCoV genome, the
MT does bind and, equally important, with what other viral proteins the MT interacts. It
will also be important to determine for both its enzymatic and binding functions whether
the MT acts as a final cleaved product, as synthesized here, or whether it acts as an
uncleaved precursor, of which there are at least 4 possibilities: MT-EndoN, MT-EndoN
ExoN, MT-EndoN-ExoN-Hel, and MT-EndoN-ExoN-Hel-RdRP.
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CHAPTER V
FUTURE DIRECTIONS

Several questions raised by the results of this study and made approachable by the
reagents produced are the following. (i) The other cis-acting elements within the 5' UTR
(the sequence represented by stem-loops I and II and stem-loop III) need to be explored
as possible binding sites for the MT.

A stem-loop III construct will need to be

constructed and used. (ii) It will be important to determine whether the binding of MT to
stem-loop IV is dependent upon its higher-order structure, as is its cis-function for
replication. (iii) It will be important to determine which, if any, of the 5'-proximal cis
acting replication elements are bound by the other enzymes encoded in ORF 1 b. (iv) It
will be important to determine which viral proteins, if any, interact with the bound
proteins in a secondary manner.

How are they assembled to make the replication

complexes? Gel shift assays using all the replication enzymes in varying combinations
can be performed in order to determine the sequence of replication complex assembly.
Additionally, the antibodies produced against these proteins can be used in pull-down
assays to study assembly. (v) It will be important to determine where the MT might bind
in other regions of the genome. My laboratory colleague Agnieszka Dziduszko has made
the observation that the MT binds the octamer-containing bulged stem-loop in the 3'
UTR. Is this playing a role in replication complex assembly or in genome cycilization?
(vi) It will be important to determine the details of the MT-RNA interactions with such
studies that might entail crystal structure analysis of the BCoV 2'-0-Methyltransferase.
This would be extremely helpful in discovering the enzyme's mechanism of action, its
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binding site at high resolution, and ultimately in designing chemotherapeutic drugs
targeted to the MT. It's thought that the MT binds to the 5' UTR in order to aid in the 5'
capping reaction; however, mutational analyses will need to be done to determine
specificity. In addition, the other cis-acting elements will need to be tested in order to
determine the details of the MT binding to the 5' UTR and catalyzing the capping
reaction. The model presented in Figure V-1 is a possible scenario for the binding of the
MT to stem-loop IV. However, more experiments (described above) will need to be
performed in order to more fully elucidate the purpose of the MT-RNA interactions.
Attempts to crystallize the MT in collaboration with the Christopher Dealwis laboratory
at the University of Tennessee in Knoxville, are currently underway. (vii) Efforts to
clone wild-type RdRP and Hel and produce antibodies to them should continue such that
a systematic characterization of replication complex structure and function can be made.

I

II

III

IV

Figure V-1. Model representing binding of the BCoV MT to cis-acting stem-loop
IV. Stem-loop IV may be providing a binding target in order for the MT to perform the
methyltransfer reaction. In vivo, the RNA structure of the mRNA may be folding into a
tertiary configuration in which the stem-loop IV bound MT is in close proximity to the 5'
terminus of the transcript.
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